Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PneumoConj versus Prevnar in healthy infants
IRCT20240626062259N1Phase 3Completed
- Sponsor
- Nivad Pharmed Salamat
- Start
- Jul 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pneumococcal 7-valent conjugate vaccine in pneumococcal disease (2 arms), sponsored by Nivad Pharmed Salamat. Primary endpoints: IgG seroresponse rate and IgG geometric mean concentration ratio. Started Jul 2024; status: completed.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on IRCT20240626062259N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240626062259N1.